$SNPS

SNPS Looks 37.0% Undervalued on GF Value™

BNP Paribas upgraded Synopsys (SNPS) to Neutral with a $420 price target, citing improved fundamentals. GF Value™ estimates SNPS is 37.0% undervalued at $414.43 vs. $657.46 intrinsic value. SNPS has a GF Score™ of 90/100, strong growth, and profitability but moderate financial strength. Insider selling totaled $48.2M over 12 months. Upcoming investor day on September 30 may provide further clarity.

Original reporting
Published Sep 24, 2026, 2:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 3:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SNPS
Bullish
medium confidence
Mentioned
$SNPS
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The analyst upgrade signals improved near‑term outlook, but valuation remains elevated; investors should weigh growth prospects against insider selling.

02

Market read

The upgrade could trigger modest buying in SNPS and related EDA stocks, offering a short‑term trade idea.

03

What to watch

Potential headwinds from AI disruption and Chinese market exposure could limit upside.

Relevance 7/10Novelty 6/10Timing: today

Background

Synopsys is the leading EDA software provider with a market cap of ~$79B, recently integrated Ansys and faces AI‑related industry shifts.

Company-level read

Ticker impact

$SNPSBullishMedium confidence
Context

BNP Paribas upgraded Synopsys (SNPS) to Neutral with a $420 price target, citing reduced downside risk and upcoming catalysts.

Expected impact

Potential upside of 5‑10% over the next few weeks if the target is validated.

Evidence & confidence

Analyst upgrade with a concrete target provides a clear actionable signal, but the stock already trades at a premium and the catalyst (investor day) is still days away.

Market effects

The upgrade may lift sentiment across the EDA software sector as peers are re‑priced.

U.S. technology stocks could see modest buying pressure.

Limited to investors tracking semiconductor design tools.

Counterpoint

The high trailing P/E and recent insider selling suggest caution; the upgrade may be premature.

Key entities

  • Synopsys Inc.

    EDA software leader (ticker SNPS).

  • BNP Paribas

    Upgraded SNPS to Neutral with a $420 price target.

Related articles

$SNPSMedAI 8/10

Why Has Synopsys Stopped Leading With Bad News?

Synopsys (SNPS) shifted its earnings call focus from past issues, like China's export restrictions and IP business underperformance, to new growth areas like Multiphysics Fusion with Ansys and agentic AI. Design Automation grew to $7.7-7.9B, while Design IP remained at $1.8B. Management expects new initiatives to boost EDA growth in 2027, but Design IP's turnaround is based on a single quarter of growth.

$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.